Noticed all the March insider buying by the CEO and namesake Constance. In todays market why isn't this bullish? FWIW, my interactions with this co., granted they were 5+ yrs in past, were positive. FWIW #2, regarding CEO name on patents, just my experience, my biotec CEO failed to distinguish authorship differences on patents from publications. That is, his name went on all publications, likewise with patents. Wise policy? no. Typical CEO ego, yes. If thats the case here, I'd be somewhat concerned.